¼¼°èÀÇ °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå - »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø : Á¦°øº°(¼ÒÇÁÆ®¿þ¾î, ¼­ºñ½º), ÃÖÁ¾ »ç¿ëÀÚº°(º´¿ø, Àå±â ÄÉ¾î ½Ã¼³), Áö¿ªº°, °æÀﺰ(2020-2030³â)
Infection Surveillance Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering (Software, Service), By End User (Hospitals, Long-term Care Facilities), By Region and Competition, 2020-2030F
»óǰÄÚµå : 1785402
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 185 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,269,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,663,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,146,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð´Â 2024³â 5¾ï 5,721¸¸ ´Þ·¯·Î, 2030³â±îÁö ¿¹Ãø±â°£ Áß CAGR 11.16%·Î °ßÁ¶ÇÑ ¼ºÀåÀÌ ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. °¨¿° °¨½Ã ¼Ö·ç¼ÇÀº º´¿øÀ» Æ÷ÇÔÇÑ ÀÇ·á½Ã¼³ÀÌ È¯ÀÚ µ¥ÀÌÅ͸¦ ÁÖ ¹× ¿¬¹æ ´ç±¹¿¡ º¸°íÇÏ´Â µ¥ »ç¿ëÇÏ´Â ¼ÒÇÁÆ®¿þ¾îÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº º´¿ø °¨¿°¿¡ ´ëÇÑ µ¥ÀÌÅ͸¦ ¼öÁýÇϰí, °¨¿° ÆÐÅÏÀ» ¿¬±¸Çϰí, Ä¿¹Â´ÏƼ ³»¿¡¼­ÀÇ °¨¿° È®´ë¸¦ ±ÔÁ¦ÇÔÀ¸·Î½á ÀÇ·á »ê¾÷¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿ø³» °¨¿°À̶õ, º´¿øÀ̳ª ÇコÄÉ¾î ¼¾Åͳ»¿¡¼­ °³Àο¡ °¨¿°ÇÏ´Â °¨¿°ÁõÀÔ´Ï´Ù. ÀÌ ¼ÒÇÁÆ®¿þ¾î´Â °¨¿°ÀÌ ¹ß»ýÇÏ¸é º´¿øÀÇ ÀÎÅÍ³Ý ÇÁ·ÎÅäÄÝ(IP) ÁÖ¼Ò¿¡ ½Å¼ÓÇÏ°Ô °æ°íÇÕ´Ï´Ù. À̸¦ ÅëÇØ HAI Àü¹®°¡¿Í °£È£»ç´Â °¨¿°µÈ ȯÀÚ¿¡°Ô ÀûÀýÇÑ Ä¡·á¸¦ ½Å¼ÓÇÏ°Ô Á¦°øÇÒ ¼ö ÀÖ¾î Å»ÃâÀ» ¿¹¹æÇÒ ¼ö ÀÖ½À´Ï´Ù. °¨¿° ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀº °Ç°­ °ü¸® ½Ã¼³¿¡¼­ °Ç°­ °ü¸® °¨¿°(HAI)ÀÇ È¿°úÀûÀÎ °ü¸®¸¦ ÃËÁøÇÏ´Â Áß¿äÇÑ ÇÁ·Î±×·¥ÀÔ´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 5¾ï 5,721¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 10¾ï 4,315¸¸ ´Þ·¯
CAGR : 2025-2030³â 11.16%
±Þ¼ºÀå ºÎ¹® º´¿ø
ÃÖ´ë ½ÃÀå ºÏ¹Ì

¿¹¸¦ µé¾î, 2024³â ¹Ì±¹ÀÇ º´¿ø µ¥ÀÌÅ͸¦ ºÐ¼®ÇÑ ¿¬±¸¿¡¼­´Â Ç×±ÕÁ¦ ³»¼º(AMR)°ú °ü·ÃµÈ ¿ø³» °¨¿°ÀÌ COVID-19 ÆÒµ¥¹Í Áß¿¡ 32% Áõ°¡Çß°í, ÆÒµ¥¹Í ÈÄÀÇ °¨¿°·üÀº ÆÒµ¥¹Í Àü ¼öÁØ¿¡ ºñÇØ 13% ³ô°Ô À¯ÁöµÇ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÀÌ ¿¬±¸ °á°ú´Â À¯ÇàÀÌ AMR¿¡ ¹ÌÄ¡´Â Áö¼ÓÀûÀÎ ¿µÇâ°ú Áö¼ÓÀûÀÎ °¨¿° Á¶Àý°ú Ç×±ÕÁ¦ ½ºÆ©¾îµå½ÊÀÇ Çʿ伺À» °­Á¶ÇÕ´Ï´Ù. HAIÀÇ ÀϹÝÀûÀÎ ¿¹·Î´Â Æó·Å, ¼ÒÈ­±â Áúȯ, ¿ä·Î °¨¿°, 1Â÷ Ç÷·ù °¨¿°, ¼ö¼ú ÈÄ °¨¿° µîÀÌ ÀÖ½À´Ï´Ù. HAIÀÇ ´Ù¹ßÀº ¼¼°è Á¤ºÎ¿¡ Áß´ëÇÑ °ü½É»çÀ̸ç, ÀÌ·¯ÇÑ »ç°í¸¦ È¿°úÀûÀ¸·Î °ü¸®ÇÏ°í °¨¼Ò½ÃŰ´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÑ Á¤Ã¥ÀÇ °³¹ß·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¿µ±¹ ÀǷẸ°Ç±¹ÀÇ 2025³â º¸°í¼­¿¡ µû¸£¸é, ÀÇ·á°ü·Ã °¨¿°Àº ȯÀÚÀÇ 7.6%¿¡¼­ ÀÎÁ¤µÇ¾úÀ¸¸ç, 2016³â¿¡ ºñÇØ 1% Áõ°¡Çß½À´Ï´Ù. ÀÌ ¼³¹®Á¶»ç´Â Áõ°¡ Ãß¼¼°¡ ¿ì·ÁµÇ´Â °ÍÀ¸·Î ¹àÇôÁ³À¸¸ç ¿µ±¹ÀÇ °Ç°­ °ü¸® ȯ°æ Àü¹Ý¿¡¼­ °¨¿° ¿¹¹æ ¹× °ü¸® ´ëÃ¥À» °­È­ÇÒ Çʿ伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¿ø³» °¨¿° Áõ°¡

ÁÖ¿ä ½ÃÀå °úÁ¦

¼Ò±Ô¸ð ÀÇ·á Á¶Á÷¿¡¼­ µµÀÔ ºñ¿ëÀÌ ³ô½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå µ¿Çâ

Ŭ¶ó¿ìµå ±â¹Ý ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼Ç

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¸ñ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå ¼¼°èÀÇ °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå : SWOT ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

Á¦16Àå Àü·«Àû Á¦¾È

Á¦17Àå ±â¾÷ ¼Ò°³¿Í ¸éÃ¥»çÇ×

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Infection Surveillance Solutions Market was valued at USD 557.21 Million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 11.16% through 2030F. An infection surveillance solution is a software used by healthcare facilities, including hospitals, to report patient data to state and federal authorities. These solutions play a crucial role in the healthcare industry by collecting data on nosocomial infections, studying infection patterns, and regulating their spread within the community. Nosocomial infections are infections transmitted to individuals within hospitals or healthcare centers. This software promptly alerts hospital Internet Protocol (IP) addresses in the event of infection occurrences. This enables HAI specialists and nurses to promptly provide appropriate treatment to infected patients, preventing outbreaks. Infection surveillance solutions are vital programs that facilitate the effective management of Healthcare-Acquired Infections (HAIs) in healthcare facilities.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 557.21 Million
Market Size 2030USD 1043.15 Million
CAGR 2025-203011.16%
Fastest Growing SegmentHospitals
Largest MarketNorth America

For instance, in 2024, a study analyzing U.S. hospital data revealed that hospital-acquired infections linked to antimicrobial resistance (AMR) rose by 32% during the COVID-19 pandemic and remain 13% higher post-pandemic compared to pre-pandemic levels. The findings underscore the lasting impact of the pandemic on AMR and the need for sustained infection control and antimicrobial stewardship. Common examples of HAIs include pneumonia, gastrointestinal illness, urinary tract infections, primary bloodstream infections, and post-surgical infections. The high incidence of HAIs is a significant concern for governments worldwide, leading to the development of policies aimed at effectively managing and reducing these incidents. According to the UK Health Security Agency's 2025 report, healthcare-associated infections were found in 7.6% of patients-marking a 1% rise compared to 2016. The survey highlights a concerning upward trend, emphasizing the need for strengthened infection prevention and control measures across healthcare settings in the UK.

Key Market Drivers

Increasing Prevalence of Hospital-Acquired Infections

The increasing prevalence of hospital-acquired infections (HAIs) is driving the demand for infection surveillance solutions. Hospital-acquired infections, also known as healthcare-associated infections, are infections that patients acquire while receiving medical treatment in healthcare facilities. These infections can lead to prolonged hospital stays, increased healthcare costs, patient discomfort, and, in severe cases, even mortality. In response to this growing concern, infection surveillance solutions are being sought after to help prevent, monitor, and manage HAIs. HAIs pose a significant threat to patient safety and well-being. The rising awareness of these concerns has prompted healthcare facilities to prioritize infection control. For instance, in 2024, healthcare-associated infections impact approximately 4.3 million patients annually in hospitals across the EU/EEA. These infections pose significant challenges to patient safety, increase hospital stays, and contribute to higher healthcare costs. Reducing their incidence remains a critical priority for healthcare systems, requiring improved infection control practices and enhanced surveillance measures throughout the region.

The increasing emphasis on hospital safety is driving the market for infection control surveillance solutions. Hospitals are actively seeking ways to enhance patient safety and reduce infection rates through improved surveillance strategies. This transformation commenced in the late 2000s with the introduction of electronic medical record systems, which allowed for more efficient and accurate patient data collection. Presently, hospitals are investing in advanced solutions to detect and predict infections, implement evidence-based protocols, and monitor outcomes over time. These solutions leverage data analytics, AI, ML, and predictive modeling to facilitate accurate identification and mitigation of infection risks. Apart from enhancing patient safety, these solutions offer potential benefits such as cost reduction, operational efficiency improvement, and optimization of care quality.

Key Market Challenges

High Cost of Deployment for Small Healthcare Organizations

The high cost of deployment for small healthcare organizations is a significant factor restraining the growth of Infection Surveillance Solutions (ISS). These solutions often require initial investment in technology, infrastructure, staff training, and ongoing maintenance. For small healthcare organizations with limited budgets and resources, the cost of implementing and sustaining infection surveillance solutions can be a barrier to adoption. Small healthcare organizations often operate with tighter budgets compared to larger institutions. The high upfront and ongoing costs associated with infection surveillance solutions can strain their financial resources, making it difficult to allocate funds for implementation. Small healthcare organizations may need to prioritize their resources for essential services and treatments. Investing in infection surveillance solutions might divert resources away from other critical needs, making the decision challenging. Beyond the initial deployment, infection surveillance solutions require ongoing maintenance, updates, and technical support. Small healthcare organizations might struggle to allocate resources for these continuous operational needs.

Key Market Trends

Cloud-based Software Solutions

Cloud-based software solutions are expected to significantly boost the Infection Surveillance Solutions (ISS) market in the future. Cloud technology offers a range of benefits that align well with the needs of healthcare organizations seeking efficient and scalable infection surveillance solutions. For instance, according to a 2022 article, 94% of companies worldwide have adopted cloud computing. This widespread adoption reflects the growing reliance on cloud-based technologies to enhance scalability, improve efficiency, and support digital transformation across various industries, making cloud computing a critical component of modern business operations. Cloud-based solutions offer scalability to accommodate the varying needs of healthcare organizations, whether they are small clinics or large hospitals. As the demand for infection surveillance solutions grows, cloud platforms can easily scale up to handle increased data volume and user activity. Traditional on-premises software solutions require significant investments in hardware, servers, and IT infrastructure. Cloud-based solutions eliminate these upfront costs, making ISS more accessible to healthcare organizations with limited resources. Cloud-based solutions are typically quicker to implement compared to on-premises alternatives. This is particularly advantageous for healthcare organizations looking to deploy infection surveillance solutions rapidly. Cloud-based solutions provide remote access to infection surveillance data for authorized personnel. Healthcare professionals can securely access and monitor infection data from various locations, enabling more efficient and timely interventions. Cloud-based infection surveillance solutions enable real-time monitoring of infection trends, allowing healthcare organizations to respond promptly to potential outbreaks and implement necessary interventions.

Key Market Players

Report Scope:

In this report, the Global Infection Surveillance Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Infection Surveillance Solutions Market, By Offering:

Infection Surveillance Solutions Market, By End User:

Infection Surveillance Solutions Market, By Region:

Company Profiles: Detailed analysis of the major companies present in the Global Infection Surveillance Solutions Market.

Available Customizations:

Global Infection Surveillance Solutions market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Infection Surveillance Solutions Market Outlook

6. North America Infection Surveillance Solutions Market Outlook

7. Europe Infection Surveillance Solutions Market Outlook

8. Asia-Pacific Infection Surveillance Solutions Market Outlook

9. South America Infection Surveillance Solutions Market Outlook

10. Middle East and Africa Infection Surveillance Solutions Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Infection Surveillance Solutions Market: SWOT Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

16. Strategic Recommendations

17. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â